Clinical trial Recruiting at 1 site Observational Ages 12 and up

Traq device test of binocular eye function in people with and without a concussion

Official title: An Early Prospective Study of the Traq™ Device for Characterization of Binocular Ocular Function in Normal Subjects and Subjects With Recent Traumatic Brain Injury

Run by Rebiscan, Inc. · NCT07742878 · Data updated 2026-11-12

This study tests the Traq device to see how well binocular eye function works in healthy people compared with people who recently had a mild-to-moderate traumatic brain injury.

Quick facts

Study typeObservational
Ages12 Years and up
SexAll
Enrollment10 (estimated)
SponsorRebiscan, Inc.
Industry-sponsored
Locations1 site (Waukee, Iowa)
StatusRecruiting
StartedJuly 14, 2026
Main results expectedOctober 2026
Study endsOctober 2026
Registry record updatedAugust 3, 2026
Trial IDNCT07742878 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 12 years or older, with no history of TBI for the normal arm, or with a history of mild-to-moderate TBI within the last six months for the post-TBI arm, who can complete study visits and assessments.

Probably not a fit

Patients with active eye diseases that affect retina reflectance, or those who are pregnant or breastfeeding, or currently enrolled in another device trial, may not benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, prospective observational study comparing binocular ocular function between normal subjects and individuals with a recent mild-to-moderate traumatic brain injury. It uses the Traq device to measure metrics such as bilateral foveal fixation, foveal binocularity, and fovea-tracked saccadic latency. The study is non-randomized and non-mmasked, enrolling participants 12 years and older who meet inclusion criteria and have no exclusion conditions that would affect device signal. Data collected will help characterize how Traq measurements differ between the two populations and establish baseline measurement characteristics. The lead sponsor is Rebiscan, Inc., with Elite Eye Care/Elite Vision Therapy as the location site in Waukee, Iowa.

Why it matters

Potential benefit: If successful, the Traq device could provide objective measurements of binocular function that may aid in understanding and monitoring visual and neurological status after traumatic brain injury.

How similar studies have gone: Previous work with binocular diagnostic devices has shown promise in characterizing ocular function, but this specific Traq device study in post-TBI individuals is an early observational effort.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 12 years or older at the time of enrollment.
2. Able to understand and sign an informed consent form (or with parent/guardian for subjects less than 18 years of age).
3. Willing and able to complete all required study visits and test assessments.
4. Subjects with no history of traumatic brain injury (normal arm).
5. Subjects with a history of mild to moderate traumatic brain injury (mTBI) within the last six months, (post-TBI arm).

Exclusion Criteria:

1. Concurrent participation in another drug or device clinical investigation.
2. Subject with a history of eye disease which could reduce, or limit reflected polarized light from the retina, such as corneal scarring, cataract, glaucoma, degenerative retinal conditions (e.g., age-related macular degeneration, diabetic retinopathy), or other conditions which may decrease device signal reflectance.
3. Subjects who are pregnant, planning to become pregnant, or are breastfeeding.

Where it's running

  • Elite Eye Care/Elite Vision Therapy
    Waukee, Iowa, United States
    Recruiting

Study contacts

  • Principal investigator: Heidi Bell, OD — Elite Eye Car / Elite Vision Therapy
  • Study coordinator: Justin Shaka
  • Email: jgshaka@rebiscan.com
  • Phone: 857-600-0982

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.